Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 261 matches for

Professor Julia Hippisley-Cox is collaborating on the University of Cambridge-led DELTA programme that aims to diagnose oesophageal cancer earlier.

Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed

Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.

Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer

Pancreatic cancer

The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.

Oxford lung cancer early detection trial reaches 400 participants

Lung cancer

The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.

£1.7 million for vaccine to prevent lung cancer

Lung cancer

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.

Funding to compare imaging modalities for liver cancer detection

Liver cancer

The DeLIVER team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.

Ultrasensitive detection of p53 cancer biomarker

Professor Jason Davis and team have developed a new sensor to selectively and quantitatively measure p53 autoantibodies in the blood, levels of which are raised in a broad range of cancers.

Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors

A computer vision challenge was set to objectively quantify the generalisability of polyp detection and mapping algorithms, and challenge participants to innovate novel methods.

First patient recruited to MILI trial

Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome has opened to recruitment

Challenges for colorectal cancer risk stratification in people with IBD using histology

A team of pathologists were unable to validate a histology-based assessment of cancer risk in people with inflammatory bowel disease (IBD).

Oxford Centre for Early Cancer Detection Symposium 2023 – a recap

Lung cancer Myeloma OxCODE travel award QResearch SCAN pathway TAPS

On Tuesday 5th December, the Oxford early cancer detection community gathered at the Mathematical Institute in Oxford to hear some highlights from OxCODE’s research in the past year and to discuss ideas for future projects.

Oxford Cancer Precision Prevention Symposium – a recap

To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.

University of Oxford Awarded £3 Million to Establish HealthTech Research Centre

The Nuffield Department of Primary Care Health Sciences wins an NIHR award for a new HealthTech Research Centre (HRC) to explore innovative Health Technology to enhance community and primary care.

OxCODE researchers at the Early Detection of Cancer Conference 2023

OxCODE travel award SCAN pathway TAPS

Oxford’s early detection research was featured at this annual event.

First private specialised haematology clinic and laboratory in sub-Saharan Africa launched

SerenOx Africa, led by Professor Anna Schuh, aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility also aims to provide early cancer detection for high-risk patients.

Collaboration announced to develop the use of AI to evaluate Barrett’s oesophagus

An agreement between Satisfai Health Inc and the University of Oxford will progress the automated assessment of Barrett’s oesophagus with the aim of determining patients most at risk of developing oesophageal cancer.

OxCODE travel awards 2023

OxCODE travel award TAPS

Congratulations to James Chettle, Masato Inoue and Eoghan Mulholland who have been awarded OxCODE funds to attend this year’s Early Detection of Cancer conference in London.

MILI trial: the start of precision cancer prevention

Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population

Disentangling a long-standing link between inflammation and cancer progression

A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.

OxCODE funding scheme awards 2023

OxCODE funding scheme

Congratulations to James McCullagh, Monica Olcina, Bethan Psaila, and their collaborators who have been awarded funding in the fourth round of the OxCODE Funding Scheme.

Model to predict 10-year risk of breast cancer

QResearch

A team of researchers led by Professor Julia Hippisley-Cox have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.

Load More

Similar stories